{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:41:52Z","timestamp":1778539312137,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jceh.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T21:29:05Z","timestamp":1654205345000},"page":"1463-1473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Profile, Patterns of Care &amp; adherence to Guidelines in Patients with Hepatocellular Carcinoma: Prospective multi-center Study"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7718-9452","authenticated-orcid":false,"given":"Akash","family":"Shukla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shraddha","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghraj","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrit","family":"Gopan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrunal","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Mohanka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7367-176X","authenticated-orcid":false,"given":"Swapnil","family":"Walke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.jceh.2022.05.006_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspec-tive","volume":"15","author":"Venook","year":"2010","journal-title":"Oncol"},{"issue":"suppl 3","key":"10.1016\/j.jceh.2022.05.006_bib2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jceh.2014.05.013","article-title":"Epidemiology of hepatocellular carcinoma in India","volume":"4","author":"Acharya","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.05.006_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and meta-bolic syndrome-position paper of the Indian national association for the study of the liver, endocrine society of India, Indian college of cardiology and Indian society of gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.05.006_bib4","unstructured":"Three-year report of PBCR 2012-2014. http:\/\/ncdirindia.org\/NCRP\/ALL_NCRP_REPORTS\/PBCR_REPORT_2012_2014\/ALL_CONTENT\/Printed_Version.htm. Accessed August 12, 2018."},{"key":"10.1016\/j.jceh.2022.05.006_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/qjmed\/hcn033","article-title":"Characteristics of hepatocel-lular carcinoma in India: a retrospective analysis of 191 cases","volume":"101","author":"Kumar","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.jceh.2022.05.006_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729240","article-title":"The role of diagnosis and treatment of underlying liver disease for the prognosis of primary liver cancer","volume":"24","author":"Shiani","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.jceh.2022.05.006_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/archsurg.136.5.528","article-title":"Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcino-ma","volume":"136","author":"Bilimoria","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.jceh.2022.05.006_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210730","article-title":"Multidisciplinary approach is associated with im-proved survival of hepatocellular carcinoma patients","volume":"14","author":"Sinn","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.05.006_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/MCG.0000000000000825","article-title":"Multidisciplinary management of hepatocellu-lar carcinoma improves access to therapy and patient survival","volume":"51","author":"Agarwal","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.05.006_bib10","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.4103\/jfmpc.jfmpc_288_19","article-title":"Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh's scale updated for 2019","volume":"8","author":"Wani","year":"2019","journal-title":"J\u00a0Fam Med Prim Care"},{"key":"10.1016\/j.jceh.2022.05.006_bib11","first-page":"649","article-title":"Toxicology and response criteria of the eastern Co-operative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1016\/j.jceh.2022.05.006_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Practice guideline committee of the ameri-can association for the study of liver diseases; practice parameters committee of the American college of gastroenterology. Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.05.006_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.jceh.2022.05.006_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.05.006_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2022.05.006_bib16","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.05.006_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepa-tocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.05.006_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address: easloffice@easloffice.eu; European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.05.006_bib19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.05.006_bib20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/jhep.2002.33324","article-title":"Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis","volume":"35","author":"Ratziu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.05.006_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178928","article-title":"Effect of national wealth on BMI: an analysis of 206,266 in-dividuals in 70 low-, middle-and high-income countries","volume":"12","author":"Masood","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.05.006_bib22","first-page":"2627","article-title":"Worldwide trends in body-mass index, under-weight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 popula-tion-based measurement studies in 128\u20229 million children, adolescents, and adults","volume":"390","author":"Bentham","year":"2017","journal-title":"Lan-cet"},{"key":"10.1016\/j.jceh.2022.05.006_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jceh.2013.08.007","article-title":"Hepatitis B virus infection can cause hepatocellular carcinoma in less advanced liver cirrhosis: a comparative study of 142 patients from north India","volume":"3","author":"Arora","year":"2013","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.05.006_bib24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2016.07.025","article-title":"Effectiveness of surveillance for hepatocellular carci-noma in clinical practice: a United States cohort","volume":"65","author":"Mittal","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.05.006_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/liv.13204","article-title":"The evolutionary scenario of hepatocellular carcinoma in Italy: an update","volume":"37","author":"Bucci","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.05.006_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000489791","article-title":"Patients with Barcelona clinic liver cancer stages B and C hepatocellular carcinoma: time for a subclassification","volume":"8","author":"Golfieri","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jceh.2022.05.006_bib27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1440-1746.2001.02476.x","article-title":"Pro-file of hepatocellular carcinoma in India: an insight into the possible etiologic as-sociations","volume":"16","author":"Sarin","year":"2001","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.05.006_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000231886","article-title":"Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India","volume":"77","author":"Paul","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jceh.2022.05.006_bib29","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.3748\/wjg.v25.i40.6041","article-title":"Role of liver biopsy in hepatocellular carcinoma","volume":"25","author":"Di Tommaso","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.05.006_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13651820410024049","article-title":"Diagnosis of hepatocellular carcinoma","volume":"7","author":"Bialecki","year":"2005","journal-title":"HPB"},{"key":"10.1016\/j.jceh.2022.05.006_bib31","first-page":"453","article-title":"HCC with low- and normal-serum alpha-fetoprotein levels","volume":"15","author":"Carr","year":"2018","journal-title":"Clin Pract (Lond)."},{"key":"10.1016\/j.jceh.2022.05.006_bib32","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.3748\/wjg.v25.i31.4360","article-title":"Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: beyond the known frontiers","volume":"25","author":"Cerrito","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.05.006_bib33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1872-034X.2007.00119.x","article-title":"Report of the 17th nationwide fol-low-up survey of primary liver cancer in Japan","volume":"37","author":"Ikai","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2022.05.006_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hepres.2003.08.002","article-title":"Report of the 15th follow-up survey of primary liver can-cer","volume":"28","author":"Ikai","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2022.05.006_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13027-020-0273-2","article-title":"Comparison of clinical features and outcomes between HBV-related and non-B non-C hepatocellular carcinoma","volume":"15","author":"Xue","year":"2020","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.jceh.2022.05.006_bib36","article-title":"Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma","volume":"10","author":"Sinn","year":"2015","journal-title":"analysis of a nationwide cohort [published correction appears in PLoS One"},{"key":"10.1016\/j.jceh.2022.05.006_bib37","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.7635","article-title":"Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences","volume":"12","author":"Ng","year":"2012","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jceh.2022.05.006_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/fon.12.183","article-title":"Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocel-lular carcinoma: results of an Italian field practice multicenter study","volume":"9","author":"Borzio","year":"2013","journal-title":"Future Oncol"},{"key":"10.1016\/j.jceh.2022.05.006_bib39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.dld.2014.02.012","article-title":"Adherence to AASLD guidelines for the treatment of hepatocel-lular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group","volume":"46","author":"Leoni","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2022.05.006_bib40","doi-asserted-by":"crossref","first-page":"S496","DOI":"10.1200\/JCO.2020.38.4_suppl.496","article-title":"The adherence to the American Association for the Study of Liver Disease (AASLD) guidelines in treating patients with hepatocellular carcinoma: institutional experience","volume":"38","author":"Manne","year":"2020","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:46Z","timestamp":1760854066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0973688322001335"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.05.006","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Profile, Patterns of Care & adherence to Guidelines in Patients with Hepatocellular Carcinoma: Prospective multi-center Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}